Acelyrin, Inc.
SLRN
$4.35
$0.102.35%
Headlines
4/29/2024
-
Globe Newswire
4/26/2024
-
ETF Channel
4/18/2024
-
Stock Options Channel
4/1/2024
-
TipRanks Financial Blog
3/29/2024
-
InvestorPlace
3/28/2024
-
The Fly
3/28/2024
-
Globe Newswire
3/27/2024
-
Globe Newswire
3/21/2024
-
Zacks Investment Research
3/20/2024
-
The Fly
3/20/2024
-
Seeking Alpha - Healthcare
3/20/2024
-
The Fly
3/20/2024
-
Globe Newswire
3/20/2024
-
FierceBiotech.com - Biotech
3/14/2024
-
The Fly
3/13/2024
-
SeekingAlpha
3/11/2024
-
Stock Options Channel
3/11/2024
-
Seeking Alpha - Healthcare
3/11/2024
-
Benzinga
3/11/2024
-
FierceBiotech.com - Biotech
3/11/2024
-
The Fly
3/11/2024
-
Globe Newswire
3/11/2024
-
Globe Newswire
2/19/2024
-
Simply Wall St
2/15/2024
-
Globe Newswire
Filings
Thursday, March 28, 2024
Sunday, December 31, 2023
Week of Jun 10 and 14 (est)
Price History
--
--
--
--
--
Corporate Info
805-730-0360
4149 Liberty Canyon Road
Agoura Hills, CA 91301
Agoura Hills, CA 91301
Business Description
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company’s lead product...
more